Literature DB >> 27179520

Quality of Life and Bariatric Surgery: Cross-Sectional Study and Analysis of Factors Influencing Outcome.

Michał Robert Janik1, Tomasz Rogula2, Ilona Bielecka3, Andrzej Kwiatkowski3, Krzysztof Paśnik3.   

Abstract

PURPOSE: The aims of our study were to compare quality of life (QOL) in obese patients after bariatric surgery with that in controls seeking surgery and to investigate which factors are associated with QOL in the Moorehead-Ardelt Quality of Life Questionnaire II (MA II).
MATERIALS AND METHODS: This was a cross-sectional study. The operated group consisted of patients after laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass. The MA II was administered by e-mail to 305 patients 12-18 months after surgery. The control groups consisted of 101 obese patients. We compared the QOL scores and considered good and very good outcomes to be satisfactory. Multiple logistic regression and correlation analysis was performed to identify factors associated with QOL.
RESULTS: In the operated group, the total MA II score was 1.70 ± 0.76, which was higher than 0.59 ± 1.17 in the control group. The score adjusted for the type of surgery was comparable. The prevalence of satisfactory QOL outcomes was similar in both post-operative subgroups and was still higher than in the control group. We identified four factors associated with higher QOL in obese patients. Weight loss was not correlated with total score in MAII.
CONCLUSIONS: This study demonstrates that patients after bariatric surgery have a higher score in MA II, which reflects better QOL. The scoring adjusted by type of operation is comparable. QOL among obese patients is dependent on age, gender, history of bariatric surgery, and partnered status. Body mass reduction was not associated with outcome in MAII.

Entities:  

Keywords:  Bariatric surgery; Confounders; Laparoscopic Roux-en-Y gastric bypass; Laparoscopic sleeve gastrectomy; Obesity; Quality of life

Mesh:

Year:  2016        PMID: 27179520      PMCID: PMC5118395          DOI: 10.1007/s11695-016-2220-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


Introduction

The aim of bariatric surgery is to improve obesity-related comorbidity and quality of life (QOL) by reducing excess weight. Many studies have shown a positive impact of surgical weight loss on QOL [1, 2]. However, limited data are available about which factors influence QOL measured by the Moorehead–Ardelt Quality of Life Questionnaire II (MA II) in obese patients, and which factors may be potential confounders. Bariatric surgery is evolving and trends in the type of procedures performed are still changing. Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) are currently the most popular types of bariatric operation [3]. The procedures are equally effective in maintaining weight loss during short-term follow-up but LRYGB seems to be more effective in resolving obesity-related comorbidity [4]. There have been several attempts to compare the procedures in terms of QOL after surgery but the amount of evidence is limited [5-7]. The aims of our study were the following: (1) to compare QOL in obese patients 12–18 months after bariatric surgery to that in controls seeking surgery and (2) to investigate which factors influence QOL outcomes in the MA II in obese patients.

Material and Methods

The study was cross-sectional and data were collected from two separate groups. The operated group comprised 28 patients at 12–18 months after LSG (post-LSG subgroup) and 30 at 12–18 months after LRYGB (post-LRYGB subgroup). The control group consisted of 101 patients seeking bariatric surgery. The questionnaires were sent via e-mail to the operated group and there was a response rate of 19 %. Preoperative data of responders were extracted from medical records. In the controls, the questionnaires were collected prior to surgery and resulted in a 90 % response rate. All participants met the following criteria for bariatric surgery [8]: BMI >40 kg/m2 or >35 kg/m2 with comorbidity, for >5 years, and failed conservative treatment for >2 years. Patients were assigned to the type of operation on the basis of baseline BMI, presence of comorbidity, and preference for a sweet-tasting diet. Informed consent was obtained from all participants included in the study. Patients with a history of depression and anxiety disorders were excluded. Patients from control group were not included in the operated group.

Operative Technique and Post-operative Management

In LSG, 75–80 % of the greater curvature was resected, forming a narrow sleeve-shaped stomach. A 36 French bougie was used to calibrate the sleeve. In LRYGB, the stomach was transected, creating a pouch of 25–30 ml in volume. Then, a gastrojejunal anastomosis was performed using a circular stapler. After that, two loops of the small intestine were stapled side to side, and a jejunostomy was created with a Roux limb length of ~150 cm. Regardless of the type of surgery, patients underwent a methylene blue solution test intraoperatively, and on post-operative day 1. If there was no leakage detected, an oral diet was resumed. The patients were discharged on post-operative day 2. In general, both procedures were performed laparoscopically with the use of five trocars.

Measurement of QOL

The groups were asked to complete the Moorehead–Ardelt Quality of Life Questionnaire II (MA II) and the department-specific questionnaire. MA II was introduced by Moorehead et al. in 2003 [9] and is used as a part of the Bariatric Analysis and Reporting Outcome System (BAROS). It is a six-item self-report questionnaire that assesses the patient’s subjective impression of QOL across six areas of general self-esteem, physical activity, social contacts, work satisfaction, sexual pleasure, and focus on eating behavior. Each item is scored from −0.5 to +0.5. The total score ranges from −3 to +3 and defines five outcome groups: poor, very poor, fair, good, and very good. Good and very good outcomes are considered as satisfactory. The department-specific questionnaire assessed body weight and height, comorbidity, partnered status, place of living, and smoking status. Because of the study design, we did not collect data regarding control weight or weight reduction.

Statistical Analysis

Analysis was performed using the SAS® software, University Edition (SAS Institute, Cary, NC, USA). To compare continuous variables, the Mann–Whitney U and unpaired Student t tests were used. Categorical variables were compared using the χ2 and Fisher’s exact tests. Statistical significance was set at p < 0.05. Multiple logistic regressions with stepwise variable selection were used to construct a model for prediction of satisfactory QOL outcome. Backward stepwise elimination and forward stepwise selection were both used to build a model. Independent variables with an association (p < 0.2) with satisfactory QOL outcome in univariate analysis were entered into the model. With backward elimination, risk factors (p < 0.2) were kept in the model, as described previously [10, 11]. Calibration of the model was tested using the Hosmer–Lemeshow goodness-of-fit test. The discriminatory capability of the model was assessed using the c-statistic, which is the same as the area under the curve. Correlation analysis was used to investigate the association between weight loss and total score in MAII. Weight loss was expressed as change in BMI (ΔBMI), percent total weight loss (%TWL), and percent excess weight loss (%EWL).

Results

General Patient Characteristics

Table 1 presents the descriptive characteristics of the patients. We enrolled 58 patients in the operated group and 101 in the control group. The operated group consisted of 10 women and 18 men after LSG (post-LSG subgroup) and 18 women and 12 men after LRYGB (post-LRYGB subgroup). The control group comprised 64 women and 37 men. The mean age of patients in the operated group was 43.6 ± 10.8 years, including 46.7 ± 10.5 years for the post-LSG subgroup and 40.6 ± 10.5 years for the post-LRYGB subgroup. The mean age of patients in the control group was 40.2 ± 9.1 years. The mean BMI of patients in the operated group was 27.6 ± 2.6, including 28.6 ± 2.7 for the post-LSG subgroup and 26.7 ± 2.2 for the post-LRYGB subgroup. The mean BMI of patients in the control group was 45.1 ± 7.4. The mean ΔBMI in the operated group was 14.8 ± 6.8, including 18.6 ± 6.7 for the post-LSG subgroup and 11.4 ± 4.7 for the post-LRYGB subgroup. %TWL and ΔBMI was significantly higher in post-LSG subgroup. %EWL was comparable in both groups.
Table 1

Descriptive characteristics of all patients involved in study

CharacteristicOperated group (n = 58)Control group (n = 101) p value
Mean age (years)43.6 ± 10.840.2 ± 9.10.12a
Gender (F/M)28/3064/370.07b
Mean BMI (kg/m2)After surgery27.6 ± 2.645.1 ± 7.4<0.01a
Before surgery45.9 ± 6.70.50a
ΔBMI (kg/m2)14.8 ± 6.8
%TWL31.5 ± 13.6
%EWL83.4 ± 19.8
Comorbidity
  HypertensionAfter surgery4 (7 %)47 (46 %)<0.01b
Before surgery19 (33 %)0.10b
  DiabetesAfter surgery0 (0)%17 (17 %)<0.01b
Before surgery11 (19 %)0.83b
Partnered status
  Partnered53 (91 %)91 (91 %)1.0b
  Non-partnered5 (9 %)10 (9 %)
Smoking status
  Never-smoker33 (58 %)38 (39)%0.01b
  Current smoker14 (25 %)21 (22 %)
  Former smoker10 (17 %)38 (39 %)
Hometown population
  <100,0001 (2 %)30 (32 %)<0.01b
  100,000–250,0005 (9 %)8 (8 %)
  250,000–500,0009 (16 %)8 (8 %)
  >500,00041 (73 %)50 (52 %)

F female; M male; %TWL % total weight loss; %EWL % excess weight loss

aThe Mann–Whitney U test was used

bFisher’s test was used

Descriptive characteristics of all patients involved in study F female; M male; %TWL % total weight loss; %EWL % excess weight loss aThe Mann–Whitney U test was used bFisher’s test was used The operated and control groups were comparable regarding gender, age, and partnered status. The prevalence of diabetes and hypertension was higher in the control group. There was a higher percentage of never smokers in the operated group. More patients from the control group live in large cities. The post-LRYGB and post-LSG subgroups were comparable regarding gender, partnered status, smoking status, and hometown population. No diabetes was observed in the operated group. There were differences in age, BMI, and hypertension between the post-operative and control groups (Table 2).
Table 2

Descriptive characteristics of patients after bariatric surgery

CharacteristicPost-LRYGB subgroup (n = 30)Post-LSG subgroup (n = 28) p value
Mean age (years)40.6 ± 10.546.7 ± 10.50.03a
Gender (F/M)18/1210/180.07b
Mean BMI (kg/m2)After surgery26.7 ± 2.228.6 ± 2.7<0.01c
Before surgery38.1 ± 4.347.1 ± 6.0<0.01c
%TWL26.6 1 ± 1.638.9 ± 13.9<0.01c
ΔBMI (kg/m2)11.4 ± 4.718.6 ± 6.7<0.01c
%EWL85.1 ± 22.781.4 ± 16.20.4c
Comorbidity
  HypertensionAfter surgery0 (0 %)4 (14 %)0.05b
Before surgery10 (33 %)9 (32 %)1.0b
  DiabetesAfter surgery0 (0 %)0 (0 %)
Before surgery9 (30 %)2 (7 %)0.04b
Partnered status
  Partnered22 (85 %)26 (96 %)0.19b
  Non-partnered4 (15 %)1 (4 %)
Smoking status
  Never-smoker19 (63 %)14 (52 %)0.62b
  Current smoker7 (23 %)7 (26 %)
  Former smoker4 (13 %)6 (22 %)
Hometown population
   < 100,0000 (0 %)1 (4 %)0.29b
  100,000–250,0003 (10 %)2 (8 %)
  250,000–500,0007 (23 %)2 (8 %)
   > 500,00020 (67 %)21 (80 %)

F female; LRYGB laparoscopic Roux-en-Y gastric bypass; LSG laparoscopic sleeve gastrectomy; M male; F female; M male; %TWL % total weight loss; %EWL % excess weight loss

aThe two-sample t test was used

bFisher’s test was used

cThe Mann–Whitney U test was used

Descriptive characteristics of patients after bariatric surgery F female; LRYGB laparoscopic Roux-en-Y gastric bypass; LSG laparoscopic sleeve gastrectomy; M male; F female; M male; %TWL % total weight loss; %EWL % excess weight loss aThe two-sample t test was used bFisher’s test was used cThe Mann–Whitney U test was used

Preoperative Data of Operated Group

The mean BMI of operated patients before surgery was 45.9 ± 6.7 including 47.1 ± 6.0 for the LSG subgroup and 38.1 ± 4.3 for the LRYGB subgroup. Nineteen patients had hypertension including ten patients in LRYGB subgroup and nine patients in LSG group. Eleven cases had diabetes, including nine patients in LRYGB subgroup and two patients in LSG group. Patients qualified to LRYGB were younger and had a higher percentage of diabetes. Preoperative characteristic of operated group was comparable to controls in terms of BMI, prevalence of diabetes, and hypertension.

QOL in Control Versus Operated Groups

In the MA II, the total score was 1.70 ± 0.76 in the operated group, which was significantly higher than 0.59 ± 1.17 in the control group (p < 0.01). Detailed analysis revealed significantly higher scores in the following areas: general self-esteem, physical activity, social contacts, and focus on eating behavior (Table 3). The QOL outcomes were significantly different between the post-operative and control groups. A satisfactory QOL outcome in MA II (endpoint) was achieved in 48 patients in the operated group and 33 in the control group [odds ratio (OR) 8.89, 95 % confidence interval (CI) 3.98–19.79, p < 0.05] (Table 4).
Table 3

Comparison of MA II scoring between post-operative and control groups

MA II domainsScoring
Operated groupControl group p value
General self-esteem0.36 ± 0.140.10 ± 0.27<0.01a
Physical activity0.31 ± 0.14−0.08 ± 0.30<0.01a
Social contacts0.33 ± 0.180.22 ± 0.26<0.01a
Work satisfaction0.25 ± 0.190.22 ± 0.250.97a
Sexual pleasure0.21 ± 0.260.12 ± 0.300.10a
Focus on eating behavior0.24 ± 0.210.00 ± 0.28<0.01a
Total score1.70 ± 0.760.59 ± 1.17<0.01b

MA II Moorehead–Ardelt quality of life questionnaire II

aThe Mann–Whitney U test was used

bThe two-sample t test was used

Table 4

Comparison of QOL outcomes between control and operated group

Groups*QOL outcome (n)
Very poorPoorFairGooda Very gooda Total satisfactory outcomes
Control (n = 101)355325833
Postoperative (n = 58)0010262248

*Fisher’s exact test p < 0.01 for distribution of endpoints between post-operative and control groups

QOL quality of life

aSatisfactory outcomes

Comparison of MA II scoring between post-operative and control groups MA II Moorehead–Ardelt quality of life questionnaire II aThe Mann–Whitney U test was used bThe two-sample t test was used Comparison of QOL outcomes between control and operated group *Fisher’s exact test p < 0.01 for distribution of endpoints between post-operative and control groups QOL quality of life aSatisfactory outcomes

Type of Bariatric Procedures and QOL

The total MA II score in the post-LSG patients was 1.71 ± 0.76 and 1.70 ± 0.77 in the post-LRYGB subgroup. Regarding detailed QOL scoring, there was no difference between patients who underwent LSG or LRYGB (Table 5). The prevalence of different outcomes was similar in both post-surgical groups (Table 6).
Table 5

Comparison of MA II scoring between post-operative subgroups

MA II domainsScoring
Post-LRYGB subgroupPost-LSG subgroup p value
General self-esteem0.35 ± 0.140.36 ± 0.150.74a
Physical activity0.31 ± 0.170.32 ± 0.120.94a
Social contacts0.36 ± 0.170.31 ± 0.180.19a
Work satisfaction0.23 ± 0.180.26 ± 0.200.37a
Sexual pleasure0.20 ± 0.230.22 ± 0.290.56a
Focus on eating behavior0.25 ± 0.230.23 ± 0.190.47a
Total score1.70 ± 0.771.71 ± 0.760.94b

LRYGB laparoscopic Roux-en-Y gastric bypass; LSG laparoscopic sleeve gastrectomy; MA II Moorehead–Ardelt quality of life questionnaire II

aThe Mann–Whitney U test was used

b t test was used

Table 6

Comparison of QOL outcomes between post-operative subgroups

Groups*QOL outcome (n)
Very poorPoorFairGooda Very gooda Total satisfactory outcomes
Post-LRYGB (n = 30)006131124
Post-LSG (n = 28)004131124

LRYGB laparoscopic Roux-en-Y gastric bypass; LSG laparoscopic sleeve gastrectomy; QOL quality of life

*Fisher’s exact test, p = 0.73, for distribution of endpoints between post-operative subgroups

aSatisfactory outcomes

Comparison of MA II scoring between post-operative subgroups LRYGB laparoscopic Roux-en-Y gastric bypass; LSG laparoscopic sleeve gastrectomy; MA II Moorehead–Ardelt quality of life questionnaire II aThe Mann–Whitney U test was used b t test was used Comparison of QOL outcomes between post-operative subgroups LRYGB laparoscopic Roux-en-Y gastric bypass; LSG laparoscopic sleeve gastrectomy; QOL quality of life *Fisher’s exact test, p = 0.73, for distribution of endpoints between post-operative subgroups aSatisfactory outcomes

Factors Associated With Increased Risk of Satisfactory QOL Outcome in MA II

Data of all 159 patients were analyzed. Of the nine examined variables, only the following were predictive for satisfactory QOL outcome in multivariate analysis: age (OR 0.955; 95 % CI 0.911–1.002), female gender (OR 0.546; 95 % CI 0.241–1.234), no history of bariatric surgery (OR 0.113; 95 % CI 0.044–0.290), and non-partnered status (OR 3.154; 95 % CI 0.752–13.222) (Table 7). Figure 1 presents predicted probability for different groups of patients. The multiple logistic regression equation was as follows: L = 3.001 + (−0.046 × Age) + (−0.303 × Female) + (−1.092 × No history of bariatric surgery) + (0.574 × Non − partnered). The model presented good discrimination (c-statistics 0.773) and good calibration (Hosmer–Lemeshow goodness-of-fit test, χ2 = 4.418, p = 0.817).
Table 7

Factors for satisfactory QOL outcome in MA II

FactorsAdjusted OR95 % wald CIEstimateStandard errorWald χ 2 p value
Constant3.0011.19946.25990.0124
Age0.9550.911–1.002−0.0460.02433.51800.0607
Female0.5460.241–1.234−0.3030.20812.11650.1457
No Hx of bariatric surgery0.1130.044–0.290−1.0920.241820.4056<0.0001
Non-partnered3.1540.752–13.2220.5740.36562.46780.1162

MA II Moorehead–Ardelt quality of life questionnaire II; QOL quality of life

Fig. 1

Probabilities for satisfactory outcomes in MA II among obese patients

Factors for satisfactory QOL outcome in MA II MA II Moorehead–Ardelt quality of life questionnaire II; QOL quality of life Probabilities for satisfactory outcomes in MA II among obese patients

Correlation Between Weight Loss and Total Score in MAII

The data of 58 operated patients were analyzed. No significant correlation was present between total score in MAII and the following psychometric variables: %TWL (r = −0.122, p = 0.36), ΔBMI (r = −0.107, p = 0.42), and %EWL (r = −0.064, p = 0.63).

Discussion

In our study, total MA II score was significantly higher in the operated than control group. Also, the percentage of patients with satisfactory QOL outcomes was significantly higher in the operated group, which reflected better QOL. However, in patients after surgery, the scoring adjusted by type of surgery was comparable. Among nine examined variables, age, gender, history of bariatric surgery, and partnered status had an influence on QOL. History of surgery had the strongest independent association with the probability of satisfactory QOL outcome. Our model had good calibration. The discriminative ability of the model was above the cutoff of 0.70. Thus, the proposed model has clinical value. On the basis of the regression equation and parameters presented in Table 7, it is possible to calculate probability of satisfactory QOL outcome in obese individuals, depending on whether they have had bariatric surgery. The study revealed that age, gender, and partnered status were confounders for QOL outcome and should be take into account in further studies about QOL and bariatric surgery. Surprisingly, BMI was not associated with QOL score. Moreover, in the detailed analysis of post-operative patients we found that the body mass reduction was not correlated with total score in MAII. Knowledge about changes in QOL after surgical weight loss is essential for every bariatric surgeon. In 2003, Ballantyne et al. reported a general improvement in QOL after bariatric surgery [12]. However, the trends in bariatric surgery have changed and new procedures like LSG and LRYGB have gained popularity. These procedures are equal in terms of excess weight loss but have a different influence on morbidity. LRYGB seems to be more effective in improving glycemic control and resolving hypertension [4]. The indications for the particular type of procedure are not established and in Poland every center has its own policy. Significant differences in QOL improvements are found between different types of bariatric surgery [1]. Considering the observed trends in bariatric surgery, there is a need for new studies comparing QOL outcome after LSG and LRYGB—the most commonly performed bariatric operations [3]. In the literature, there is little about the difference between these two procedures in terms of QOL. Our results corresponded to findings reported by Zangh et al. [5] and Major et al. [6]. It is important to note that these authors used the same questionnaire for the assessment of QOL as we did. Also, the study by Peterli et al., where the authors used the Gastrointestinal Quality of Life Index (GQLI), revealed no difference between post-LRYGB and post-LSG patients [7]. Thus, we provided further evidence that both procedures are equal in terms of QOL improvement. Many believe that weight loss reflects a successful outcome after bariatric surgery. However, in our study, QOL was not dependent on BMI. Likewise, Müller et al. analyzed factors influencing QOL in 104 patients and found no correlation between BMI and QOL [13]. Furthermore, we found that the QOL outcome in MAII was not dependent on %TWL, %EWL, and ΔBMI. Major et al. stated that QOL was not dependent on percentage of excess weight loss (EWL%) [6]. Their results were similar to those of Sarwer et al., which showed no correlation between body mass reduction and improvement in QOL [14]. We should open a discussion about what is responsible for good QOL outcome after bariatric surgery.

Limitations

We are aware that our study had several limitations. First, the sample size was small. It has to be pointed out that small populations do not give a strong insight. Small sample size resulted from the low response rate in operated group. This is the major flaw of the study. Sensitive nature of the item referring to sexual life in MAII may have contributed to low compliance in the operated group. Unfortunately, distributing questionnaires via e-mails turned out to be ineffective. Face-to-face collecting data resulted in higher response rate. The present study was a cross-sectional and we did not use matching in the study. Thus, there were some differences in the characteristics of the analyzed groups. Smoking status and hometown population may be confounding factors and should be considered in future studies. Last, the period of 12–18 months of observation was short. There is a need for long-term observation studies to assess long-term effects of bariatric surgery on the quality of life.

Conclusion

This study demonstrates that patients after bariatric surgery have a higher score in the MA II, which reflects better QOL. However, the scoring adjusted for the type of operation is comparable. QOL among obese patients is dependent on age, gender, history of bariatric surgery, and partnered status. Weight loss was not associated with better outcome in MAII.
  13 in total

1.  Quality of life after bariatric surgery--a comparative study of laparoscopic banding vs. bypass.

Authors:  Markus K Müller; Christa Wenger; Marc Schiesser; Pierre-Alain Clavien; Markus Weber
Journal:  Obes Surg       Date:  2008-05-07       Impact factor: 4.129

2.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

3.  Changes in quality of life and body image after gastric bypass surgery.

Authors:  David B Sarwer; Thomas A Wadden; Reneé H Moore; Miriam H Eisenberg; Steven E Raper; Noel N Williams
Journal:  Surg Obes Relat Dis       Date:  2010-08-13       Impact factor: 4.734

Review 4.  Quality of Life Outcomes of Bariatric Surgery: A Systematic Review.

Authors:  Aleeya Hachem; Leah Brennan
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

5.  A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome.

Authors:  Yong Zhang; Hongzhi Zhao; Zhanguo Cao; Xiangyu Sun; Chen Zhang; Wang Cai; Rong Liu; Sanyuan Hu; Mingfang Qin
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

6.  The validation of the Moorehead-Ardelt Quality of Life Questionnaire II.

Authors:  Melodie K Moorehead; Elisabeth Ardelt-Gattinger; Hans Lechner; Horacio E Oria
Journal:  Obes Surg       Date:  2003-10       Impact factor: 4.129

7.  Quality of Life After Bariatric Surgery.

Authors:  Piotr Major; Maciej Matłok; Michał Pędziwiatr; Marcin Migaczewski; Piotr Budzyński; Maciej Stanek; Michał Kisielewski; Michał Natkaniec; Andrzej Budzyński
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

8.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16

9.  Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass.

Authors:  Ralph Peterli; Yves Borbély; Beatrice Kern; Markus Gass; Thomas Peters; Martin Thurnheer; Bernd Schultes; Kurt Laederach; Marco Bueter; Marc Schiesser
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

10.  Interdisciplinary European Guidelines on metabolic and bariatric surgery.

Authors:  Martin Fried; Volkan Yumuk; Jean-Michel Oppert; Nicola Scopinaro; Antonio J Torres; Rudolf Weiner; Yuri Yashkov; Gema Frühbeck
Journal:  Obes Facts       Date:  2013-10-11       Impact factor: 3.942

View more
  23 in total

1.  Quality of Life and Weight Loss in the Long Term After Gastric Bypass.

Authors:  R S R Álvares; A M R Beleigoli; A G M Cançado; N H K Magario; L G O Freitas; V G van Eijk; M M N H Ferreira; M F H S Diniz
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

2.  The Safety and Benefits of Laparoscopic Sleeve Gastrectomy in Elderly Patients: a Case-Control Study.

Authors:  Katarzyna Bartosiak; Anna Różańska-Walędziak; Maciej Walędziak; Piotr Kowalewski; Krzysztof Paśnik; Michał R Janik
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

3.  QUALITY OF LIFE AFTER VERTICAL GASTRECTOMY EVALUATED BY THE BAROS QUESTIONNAIRE.

Authors:  Giselle Abigail Mendes; Guilherme Pedroso Vargas
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

4.  Predictors of Changes in Health-Related Quality of Life 6 and 12 months After a Bariatric Procedure.

Authors:  Carolin Peterhänsel; Michaela Nagl; Birgit Wagner; Arne Dietrich; Anette Kersting
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

5.  Adverse Childhood Experiences in a Post-bariatric Surgery Psychiatric Inpatient Sample.

Authors:  Kathryn Fink; Colin A Ross
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

6.  Alcohol Consumption in Obese Patients Before and After Gastric Bypass as Assessed with the Alcohol Marker Phosphatidylethanol (PEth).

Authors:  Lisa Walther; Carl-Magnus Brodén; Anders Isaksson; Jan L Hedenbro
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

7.  Transition from a circular to a linear stapling protocol in laparoscopic Roux-en-Y gastric bypass surgery and its impact on quality of life: a 5-year outcome study.

Authors:  Hugo Teixeira; Sascha Halvachizadeh; Michel P J Teuben; Pascal Probst; Markus K Muller
Journal:  Langenbecks Arch Surg       Date:  2022-08-10       Impact factor: 2.895

8.  Effectiveness and Safety of Roux-en-Y Gastric Bypass in Elderly Patients-Systematic Review and Meta-analysis.

Authors:  Paweł Marczuk; Michał J Kubisa; Michał Święch; Maciej Walędziak; Piotr Kowalewski; Piotr Major; Michał Pędziwiatr; Krzysztof Paśnik; Michał R Janik
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

9.  Generic Health-Related Quality of Life May Not Be Associated with Weight Loss 4 Years After Bariatric Surgery: a Cross-Sectional Study.

Authors:  Vigdis Dagsland; Randi Andenæs; Tor-Ivar Karlsen
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

10.  Evaluation of Eating Habits and Quality of Life in Postbariatric Surgery Patients and Their Family Members: A Case-Control Study.

Authors:  Carla Ibrahim; Joane Matta; Kàtia Lurbe I Puerto; Yonna Sacre
Journal:  J Nutr Metab       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.